When will we get back to normal? Dr. Chip Schooley, a national leader in getting students successfully back to campus, offers some insight.
Q&A: What is realistic when it comes to herd immunity?
As K-12 students return, schools shouldn’t obsess over pandemic ‘learning loss’
After months of turmoil and fear, it’s important to focus on emotional support for students and teachers, scholars say.
Text-message ‘nudges’ can encourage holdouts to get COVID vaccination, study finds
The researchers said their findings held true across all demographics, including groups that have been hesitant to receive the vaccine.
Why does it still feel so complicated to get back to ‘normal’? Pandemic cave syndrome explained
Reentering the public sphere after 18 months in isolation is no simple feat, scientists say.
UC Davis earns national award for COVID-19 response
The Healthy Davis Together initiative has earned national acclaim for its holistic approach to addressing the COVID crisis.
How concerned should we be about the Delta variant?
Experts share their thoughts about the SARS-CoV-2 variant, which is now in nearly every state.
The ongoing urban exodus
Could San Francisco and L.A. become affordable again? Possibly, says economist Jan Brueckner.
Turns out, designing a COVID vaccine was easy
The hard part was everything that came next, says UCSF alum Stephen Hoge, president of Moderna.
Research aims for best ways to treat COVID-19 at home
10,000 participants sought for online, app-based surveys designed by UCLA, UC Merced and Illinois.
Cross-border effort to vaccinate 10,000 maquiladora workers
UC San Diego Health is vaccinating about 1,500 workers daily at a mobile clinic in Baja California.
Feeling post-lockdown anxiety? We’ve got you covered.
Experts provide advice on navigating COVID-19 reopenings and webinars to boost your resiliency.
Should businesses require vaccines? That’s fine, most California voters say
The new Berkeley IGS Poll finds powerful vaccine resistance among GOP voters, however.